Literature DB >> 31815768

Changing treatment landscape for early cervical cancer: outcomes reported with minimally invasive surgery compared with an open approach.

Alexander Melamed1, Pedro T Ramirez2.   

Abstract

PURPOSE OF REVIEW: The aim of the article is to review recent studies that compare the oncologic efficacy of minimally invasive radical hysterectomy with that of open radical hysterectomy. RECENT
FINDINGS: The Laparoscopic Approach to Cervical Cancer (LACC) trial, a randomized study design to test the hypothesis that minimally invasive radical hysterectomy is not inferior to open radical hysterectomy, was stopped early by the data and safety monitoring committee after enrolling 631 of a planned 740 patients. The disease-free survival rate at 4.5 years was 86% among women assigned to minimally invasive surgery and 96.5% in those who underwent open surgery (hazard ratio [HR] 3.74; 95% confidence interval [CI] 1.63-8.58). Minimally invasive surgery was also associated with inferior overall survival (HR 6.00; 95% CI 1.44-12.7). Recent well designed, adequately powered observational studies mostly corroborate the findings of the LACC trial.
SUMMARY: After a decade of widespread acceptance and increasing popularity, the preponderance of evidence now suggests that minimally invasive radical hysterectomy for cervical cancer confers an excess risk of recurrence and death compared with open abdominal radical hysterectomy.

Entities:  

Mesh:

Year:  2020        PMID: 31815768     DOI: 10.1097/GCO.0000000000000598

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  2 in total

1.  The Landmark Series: Minimally Invasive Surgery for Cervical Cancer.

Authors:  Derman Basaran; Mario M Leitao
Journal:  Ann Surg Oncol       Date:  2020-10-30       Impact factor: 5.344

2.  The Role of Minimally Invasive Surgery in the Care of Women with Ovarian Cancer: A Systematic Review and Meta-analysis.

Authors:  Anne Knisely; Charlotte R Gamble; Caryn M St Clair; June Y Hou; Fady Khoury-Collado; Allison A Gockley; Jason D Wright; Alexander Melamed
Journal:  J Minim Invasive Gynecol       Date:  2020-11-14       Impact factor: 4.314

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.